|
70
|
243
|
4qw3F |
Ycp beta5-c63f mutant in complex with bortezomib |
|
68
|
242
|
4qvpD |
Ycp beta5-m45t mutant in complex with bortezomib |
|
67
|
244
|
4qlvB |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
69
|
212
|
4qwgK |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
62
|
231
|
4qz0E |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qwjH |
Ycp beta5-a49t-mutant in complex with carfilzomib |
|
59
|
238
|
4r3oF |
Human constitutive 20s proteasome |
|
57
|
204
|
4qwgI |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
65
|
212
|
4qw3K |
Ycp beta5-c63f mutant in complex with bortezomib |
|
70
|
244
|
4qv4B |
Ycp beta5-m45t mutant |
|
66
|
242
|
4qw4D |
Ycp in complex with carfilzomib |
|
62
|
241
|
4qz0G |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
57
|
204
|
4qzxI |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
73
|
212
|
4qwfK |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
60
|
243
|
4r3oD |
Human constitutive 20s proteasome |
|
60
|
196
|
4qz2N |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
233
|
4qvyM |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
61
|
195
|
4qv1J |
Ycp beta5-m45a mutant |
|
67
|
233
|
4qvqM |
Ycp beta5-m45i mutant in complex with bortezomib |
|
64
|
244
|
4qz7B |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
195
|
4qwsJ |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
61
|
196
|
4qv5N |
Ycp beta5-m45i mutant |
|
66
|
250
|
4r00A |
Ycp beta5-c52f mutant in complex with omuralide |
|
62
|
196
|
4qluN |
Ycp in complex with tripeptidic epoxyketone inhibitor 9 |
|
59
|
222
|
4qz1L |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
56
|
204
|
4qvwI |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
70
|
242
|
4qv1D |
Ycp beta5-m45a mutant |
|
56
|
204
|
4qw6I |
Ycp beta5-m45v mutant in complex with carfilzomib |
|
59
|
226
|
4qvvH |
Ycp beta5-a49v mutant in complex with bortezomib |
|
71
|
250
|
4r67C |
Human constitutive 20s proteasome in complex with carfilzomib |
|
57
|
222
|
4qwkL |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
71
|
243
|
4qwfF |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
61
|
195
|
4qv8J |
Ycp beta5-c52f mutant |
|
70
|
212
|
4qlsK |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
62
|
195
|
4r00J |
Ycp beta5-c52f mutant in complex with omuralide |
|
72
|
240
|
4qw1C |
Ycp beta5-a50v mutant in complex with bortezomib |
|
57
|
204
|
4quyI |
Ycp beta5-a49s-mutant |
|
65
|
240
|
4r18C |
Ligand-induced lys33-thr1 crosslinking at subunit beta5 of the yeast 20s proteasome |
|
64
|
231
|
4qz3E |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qwlH |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
61
|
231
|
4qvpE |
Ycp beta5-m45t mutant in complex with bortezomib |
|
67
|
233
|
4qv3M |
Ycp beta5-m45v mutant |
|
63
|
241
|
4qw4G |
Ycp in complex with carfilzomib |
|
69
|
212
|
4qv7K |
Ycp beta5-a50v mutant |
|
63
|
241
|
4qv7G |
Ycp beta5-a50v mutant |
|
68
|
244
|
4qwxB |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
61
|
222
|
4qltL |
Ycp in complex with tripeptidic epoxyketone inhibitor 2 (pr924) |
|
69
|
240
|
4qxjC |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
68
|
249
|
4r17A |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
62
|
195
|
4qwkJ |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |